Short-term activation by low 17β-estradiol concentrations of the Na+/H+ exchanger in rat aortic smooth muscle cells: Physiopathological implications

Endocrinology

Volumn 144, Issue 10, 2003, Pages 4315-4324

  Incerpi, Sandra ^a   D'Arezzo, Silvia ^a   Marino, Maria ^a   Musanti, Roberto ^b   Pallottini, Valentina ^a   Pascolini, Andrea ^a   Trentalance, Anna ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b Newron Pharmaceuticals   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 (ETHYL N ISOPROPYL)AMILORIDE; AMILORIDE DERIVATIVE; CARBOXYFLUORESCEIN; CYCLIC AMP; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; INOSITOL 1,4,5 TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTON; SODIUM ION; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; CELL ACTIVATION; CELL PH; CONCENTRATION RESPONSE; DRUG EFFECT; ENZYME PHOSPHORYLATION; FEMALE; FLUORESCENCE; IMMUNOBLOTTING; ISOMER; LOW DRUG DOSE; MALE; MUSCLE CONTRACTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE;

ANIMALS; AORTA; CARDIOVASCULAR DISEASES; CELL DIVISION; ESTRADIOL; FEMALE; HOMEOSTASIS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR FLUID; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NOREPINEPHRINE; OSMOLAR CONCENTRATION; PHENYLEPHRINE; RATS; RATS, WISTAR; SODIUM-HYDROGEN ANTIPORTER; TIME FACTORS;

EID: 0141562158     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0495     Document Type: Article

References (65)

1. Beato M, Klug J 2000 Steroid hormone receptors: an update. Hum Reprod Update 6:225-236
2. Wehling M 1997 Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59:365-393
3. Kelly MJ, Levin ER 2001 Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152-156
4. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptor (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319
5. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER 2002 ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115
6. Nadal A, Dìaz M, Valverde MA 2001 The estrogen trinity: membrane, cytosolic and nuclear effects. News Physiol Sci 16:251-255
7. Migliaccio A, Di Domenico M, Castoria G, De Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
8. Falkenstein E, Tillman H-C, Christ M, Feuring M, Wehling M 2000 Multiple actions of steroids hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 52:513-555
9. 3 mediates the estrogen receptor activity expressed in human cells. Mol Cell Endocrinol 182:19-26
10. + channels in human coronary artery smooth muscle cells. Cardiovasc Res 53:650-661
11. Jovanovic A, Jovanovic S 1999 Estrogen and vascular system: more question for the future. Cardiovasc Res 42:9-11
12. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
13. Stallone JN, Crofton JT, Share L 1991 Sexual dimorphism in vasopressin-induced contraction of rat aorta. Am J Physiol 260:H453-H458
14. Gisclard V, Flavahan NA, Vanhoutte PM 1987 α Adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17β-estradiol. J Pharmacol Exp Ther 240:466-470
15. White MM, Zamudio S, Stevens T, Tyler R, Lindenfeld J, Leslie K, Moore LG 1995 Estrogen, progesterone and vascular reactivity: potential cellular mechanisms. Endocr Rev 16:739-751
16. Dubey RK, Jackson EK 2001 Estrogen-induced cardiorenal protection: potential cellular, biochemical and molecular mechanisms. Am J Physiol 280:F365-F388
17. Norman AW, Litwack G 1997 Estrogens and progestins. In: Hormones. 2nd ed. London, New York: Academic Press; 361-386
18. Wray S 1988 Smooth muscle intracellular pH: measurement, regulation and function. Am J Physiol 254:C213-C225
19. + exchangers. J Biol Chem 275:1-4
20. Incerpi S, Spagnuolo S, Terenzi F, Leoni S 1996 EGF modulation of Na/H antiport in rat hepatocytes: different sensitivity in adult and fetal cells. Am J Physiol 270:C841-C847
21. + antiportin L-6 myoblasts: high molecular specificity for the 3, 3′, 5-triiodo-L-thyronine. Endocrinology 140:683-689
22. Incerpi S, De Vito P, Luly P, Spagnuolo S, Leoni S 2002 Short-term effects of thyroid hormones and 3, 5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. Endocrinology 143:1660-1668
23. Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Buè MC, De Vito P, Garaci E, Rotilio G 1997 Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J Biol Chem 272:2700-2708
24. + antiport by atrial natriuretic factor in rat aortic smooth muscle cells. Am J Physiol 273:C643-C652
25. + antiport and proliferation in rat aortic smooth muscle cells. Am J Physiol 277:C814-C822
26. Barillari G, Albonici L, Incerpi S, Bogetto L, Pistritto G, Volpi A, Ensoli B, Manzari V 2001 Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing α5β1 integrin expression and function. Atherosclerosis 154:377-385
27. + exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 39:747-753
28. + exchanger regulatory factor. Endocrinology 140:2976-2982
29. Ross R 1971 The smooth muscle cells. In vivo synthesis of connective tissue proteins. J Cell. Biol 50:172-186
30. i, cell volume, and bile secretion. Annu Rev Physiol 54:415-438
31. Thomas JA, Buchsbaum RN, Zimniak A, Racker E 1979 Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18:2210-2218
32. + antiporter potentiates growth and retinoic acid-induced differentiation of P19 embryonal carcinoma cells. J Biol Chem 272:26545-26549
33. Marino M, Distefano E, Caporali S, Ceracchi G, Pallottini V, Trentalance A 2001 β-Estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells. J Cell Physiol 188:170-177
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
35. Bhalla RC, Toth KF, Bhatty RA, Thompson LP, Sharma RV 1997 Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. Am J Physiol 272:H1996-H2003
36. Dubey RK, Tyurina YY, Tyuri VA, Gillespie DG, Branch RA, Jackson EK, Kagan VE 1999 Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth Circ Res 84:229-239
37. Hwang H-C, Lee K-H, Jang Y 2002 Inhibition of MEK1, 2/ERK mitogenic pathway by estrogen with antiproliferative properties in rat aortic smooth muscle cells. J Steroid Biochem Biol 80:239-256
38. Farhat MY, Lavigne MC, Ramwell PW 1996 The vascular protective effects of estrogen. FASEB J 10:615-624
39. Rosenfeld CR, White RE, Roy T, Cox BE 2000 Calcium-activated potassium channels and nitric oxide coregulate estrogen-induced vasodilation. Am J Physiol 279:H319-H328
40. Marino M, Pallottini V, Trentalance A 1998 Estrogens cause rapid activation of IP3-PKC-alpha signal transduction pathway in HEPG2 cells. Biochem Biophys Res Commun 245:254-258
41. 2+ in the cytosol. Biochem J 344:39-46
42. Mendelsohn ME 2000 Mechanism of estrogen action in the cardiovascular system J Steroid Biochem Mol Biol 74:337-343
43. Crane FL, Sun L, Clark MG, Grebing C, Löw H 1985 Transplasma-membrane redox systems in growth and development. Biochim Biophys Acta 811:233-264
44. Favoni RE, De Cupis A 1998 Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal. Trends Pharm Sci 19:406-415
45. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW 1997 Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 273:L119-L126
46. Goetz RM, Thatte HS, Prabhakar P, Cho MR, Michel T, Golan DE 1999 Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96:2788-2793
47. Gu Q, Korach KS, Moss RL 1999 Rapid action of 17β-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 140:660-666
48. Ropero AB, Soria B, Nadal A 2002 A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 16:497-505
49. Lieberherr M, Grosse B, Kachkache M, Balsan S 1993 Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J Bone Miner Res 8:1365-1376
50. Zhang Z, Maier B, Santen RJ, Song RX 2002 Membrane association of estrogen receptor α mediates estrogen effect on MAPK activation. Biochem Biophys Res Commun 294:926-933
51. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM 2002 Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway. J Neurochem 82:674-682
52. Keshamouni VG, Mattingly RR, Reddy KB 2002 Mechanism of 17-β-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HERK2 and PKC-δ. J Biol Chem 277:22558-22565
53. Lu Q, Ebling H, Baur WE, Karas RH 2002 MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor α. FEBS Lett 516:1-8
54. Davis PJ, Tillmann HC, Davis FB, Wehling M 2002 Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones. J Endocrinol Invest 25:377-388
55. 1 gene transcription in HepG2 cells. Mol Biol Cell 13:3270-3279
56. Vasudevan N, Ogawa S, Pfaff D 2002 Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. Physiol Rev 82:923-944
57. Gaskell WH 1880 On the tonicity of the hearth and blood vessels. J Physiol 3:48-75
58. Coleman KM, Smith CL 2001 Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci 6:D1379-D1391
59. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A 1994 Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol 8:910-918
60. Demay F, De Monti M, Tiffoche C, Vaillant C, Thieulant ML 2001 Steroid-independent activation of ER by GnRH in gonadotrope pituitary cells. Endocrinology 142:3340-3347
61. + exchanger NHE3. J Biol Chem 276:40761-40768
62. Lee MW, Severson DL 1994 Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol 267:C659-C678
63. Horowitz A, Menice CB, Laporte R, Morgan KG 1996 Mechanisms of smooth muscle contraction. Physiol Rev 76:967-1002
64. Dessy C, Kim I, Sougnez CL, Laporte R, Morgan KG 1998 A role for MAP kinase in differentiated smooth muscle contraction evoked by α-adrenoceptor stimulation. Am J Physiol 275:C1081-C1086
65. Xiao D, Zhang L 2002 ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: effect of pregnancy. Am J Physiol 282:H292-H300